Chapter 8. Meaningful Use Overview

What actually is meaningful use? Even though the term arises whenever the current U.S. healthcare system is under discussion, we find very few people who are actually familiar with the specifics of each guideline and requirement. A little background first is important.

Many people wrongly believe that meaningful use was part of the healthcare legislation passed by Congress in 2010. In fact, it was part of the economic stimulus passed more than a year before, the American Reinvestment Recovery Act (ARRA). That bill set aside $20 billion for incentives to encourage medical practices and hospitals to use new technologies such as EHRs—but in specific and accountable ways that are denoted by the term meaningful use. These uses include gathering clear statistics on patient illnesses, improving interaction with patients and others using the Internet, and utilizing accuracy and error control systems such as ePrescribing.

As with many government regulations, the ARRA offers a problematic amount to sort through. We have digested and analyzed the 5,000+ pages of legislation and rule-making by HHS, ONC, and CMS and created this concise interactive guide to help you understand the specific criteria that can make you meaningful use compliant and eligible to receive the current incentive payments. The guidelines are very different depending on whether you are part of an outpatient practice (ambulatory) or a hospital facility (inpatients). We list the outpatient guidelines first, followed by inpatient facilities.

Meaningful use objectives are broken down into two distinct groups for determining Stage 1 (the current year) compliance: a core set of objectives and a menu set. A meaningful user must satisfy all objectives under the core set, and 5 of the 10 menu set objectives. In the list that follows, the “Criteria” sections define the meaningful use objectives, and the “Measure” sections define the reporting threshold that must be met to demonstrate meaningful use for the associated objective.

Outpatient Guidelines and Requirements

All of the measures in the core set are required for meaningful use compliance.

Because of the fluid nature of the meaningful use requirements and the ongoing rule-making, it is important to check with the registration website for the latest information:

Guideline #1
Computerized Provider Order Entry (CPOE)

Use of CPOE for medication orders directly entered by any licensed healthcare professional who can enter orders into the medical record per state, local, and professional guidelines. This guideline covers ePrescribing as well as the recording of medications that are dispensed and administered within the facility.

Measure

More than 30% of unique patients seen by the eligible provider (eligible hospital’s or critical access hospital’s [CAH] inpatient or emergency department), who have at least one medication in their medication list, have at least one medication order entered using CPOE.

Guideline #2
Drug Allergy Checking

Implement drug-drug and drug-allergy interaction checks. Typically this guideline involves both drug-to-allergy and drug-to-drug contraindications, although there is flexibility in the guidelines text in this regard.

Guideline #2 Measure

The eligible hospital’s or CAH’s inpatient or emergency department has enabled this functionality for the entire EHR reporting period.

Guideline #3
ePrescribing (eRx)

Generate and transmit permissible prescriptions electronically (eRx). As a practical matter, at the time of this writing, only Surescripts is recognized as a valid bureau for the transmission of electronic prescriptions to pharmacies for outpatient facilities, although the guideline itself does not mention Surescripts by name.

Measure

More than 40% of all permissible prescriptions written by the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department) are transmitted electronically using certified EHR technology.

Guideline #4
Record Demographics

These include preferred language, gender, race, ethnicity, and date of birth. Some of that data is already tracked by most facilities, but preferred language, race, and ethnicity are new demographics to many lines of care.

Measure

More than 50% of all unique patients seen by the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department) have demographics recorded as structured data.

Guideline #5
Problem List

Maintain an up-to-date problem list of current and active diagnoses.

Measure

More than 80% of all unique patients seen by the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department) have at least one entry or an indication, recorded as structured data, that no problems are known for the patient. Structured data here refers to the ability to report distinctly on individual problems by code. A clinical note recorded during a patient-provider interaction is insufficient to comply with this guideline.

Guideline #6
Medication List

Maintain an active medication list detailing medications the patient is actively taking that are prescribed by the provider’s facility or reported by the patient. Again, this guidelines requires data on each individual medication and cannot be complied with using only text clinical notes.

Measure

More than 80% of all unique patients seen by the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department) have at least one entry (or an indication that the patient is not currently prescribed any medication), recorded as structured data.

Guideline #7
Allergy List

Maintain an active medication allergy list that tracks medication allergies, at a minimum. All meaningful use certified systems to date also permit tracking of environmental, food, and other miscellaneous allergies as well as medications.

Measure

More than 80% of all unique patients seen by the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department) have at least one entry (or an indication that the patient has no known medication allergies) recorded as structured data.

Guideline #8
Vital Signs

Record patient vitals as part of typical workflow. Vital signs include taking height, weight, and blood pressure, calculating and displaying body mass index (BMI), and plotting and displaying growth charts for children 2 to 20 years old including BMI. This measure will be a significant workflow change for many types of facilities not accustomed to tracking vital statistics with this level of detail on each visit. A few select exemptions apply; please check CMS advisories for more information. The reasoning for this measure, even in lines of care where the necessity for vitals might not be immediately apparent, is that vital statistics provide a solid evidentiary base for earlier prevention of the most problematic chronic diseases, and each interaction with a provider of any specialty is a good opportunity for this basic prevention step.

Measure

For more than 50% of all unique patients age 2 and over seen by the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department), record height, weight, and blood pressure as structured data.

Guideline #9
Smoking Status

Record smoking status for patients 13 years old or older. Again, this guideline applies to all specialties, even those that have not historically tracked this information and even if it is not immediately obvious how it might be connected to their practices. Smoking-related illness remains a significant cause of adverse health, and any interaction with a medical provider of any kind is a good opportunity to help patients stop smoking or to create correlating data about all types of illness and smoking.

Measure

More than 50% of all unique patients 13 years old or older seen by the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department) have smoking status recorded.

Guideline #10
Clinical Decision Support (CDS)

Implement one clinical decision support rule relevant to specialty or high clinical priority, along with the ability to track compliance for this rule. Clinical decision support remains the holy grail of EHRs in many circles. It is an advanced concept where the system can apply logical conditions to known data points and make recommendations or present evidentiary advisements about possible diagnosis, treatment, and outcomes for the patient. CDS is a radical jump toward consistent and systematized care, which is still rare in the United States today. CDS is expected to play a larger and larger role as guidelines continue to expand in future years. This guideline provides enormous flexibility in compliance and sets a low bar, requiring the provider to implement only a single CDS rule, no matter how simplistic. To a large extent, this guideline is an indicator and placeholder to introduce facilities to the concept.

Measure

Implement one clinical decision support rule.

Guideline #11
Report Clinical Quality Measures

Report ambulatory clinical quality measures to CMS or the states. This guideline takes the big step of actually demonstrating meaningful use compliance by submitting the summarized numbers, proving compliance with each guideline.

Measure

For 2011, provide aggregate numerator, denominator, and exclusions through attestation to the state or federal government through the web-based reporting system. The specific measures for outpatient facilities are itemized in the list that follows. Not all items have to be reported to be compliant. If you try to identify the heart of meaningful use, you could locate it in the ability to answer all of the questions in the list. These questions have been identified as critical by the leading agencies involved in funding and researching health and healthcare. Having a large, concise, and accurate pool of data regarding these issues is the best chance we have to improve patient outcomes in the system. Although the list is dense and filled with confusing terminology, it is important to spend a little time reviewing these questions and determining how your organization will need to change in order to be able to answer them.

NQF 0421
PQRI 128
Title: Adult Weight Screening and Follow-Up
Description: Percentage of patients aged 18 years and older whose BMI was calculated in the past six months or during the current visit and was documented in the medical record, in addition to which, if the most recent BMI is outside parameters, a follow-up plan is documented.
NQF 0013
Title: Hypertension: Blood Pressure Measurement
Description: Percentage of patient visits for patients aged 18 years and older with a diagnosis of hypertension who have been seen for at least two office visits, with blood pressure (BP) recorded.
NQF 0028
Title: Preventive Care and Screening Measure Pair: a. Tobacco Use Assessment, b. Tobacco Cessation Intervention
Description: a. Percentage of patients aged 18 years and older who have been seen for at least two office visits and who were queried about tobacco use one or more times within 24 months b. Percentage of patients aged 18 years and older identified as tobacco users within the past 24 months, who have been seen for at least two office visits, and who received cessation intervention.
NQF 0041
PQRI 110
Title: Preventive Care and Screening: Influenza Immunization for Patients ≥ 50 Years Old
Description: Percentage of patients aged 50 years and older who received an influenza immunization during the flu season (September through February).
NQF 0024
Title: Weight Assessment and Counseling for Children and Adolescents
Description: Percentage of patients 2 to 17 years of age who had an outpatient visit with a Primary Care Physician (PCP) or OB/GYN and who had evidence of BMI percentile documentation, counseling for nutrition, and counseling for physical activity during the measurement year.
NQF 0038
Title: Childhood Immunization Status
Description: Percentage of children 2 years of age who had four diphtheria, tetanus and acellular pertussis (DTaP); three polio (IPV), one measles, mumps and rubella (MMR); two H influenza type B (HiB); three hepatitis B (Hep B); one chicken pox (VZV); four pneumococcal conjugate (PCV); two hepatitis A (Hep A); two or three rotavirus (RV); and two influenza (flu) vaccines by their second birthday. The measure calculates a rate for each vaccine and nine separate combination rates.
NQF 0059
PQRI 1
Title: Diabetes: Hemoglobin A1c Poor Control
Description: Percentage of patients 18 to 75 years of age with diabetes (type 1 or type 2) who had hemoglobin A1c > 9.0%.
NQF 0064
PQRI 2
Title: Diabetes: Low Density Lipoprotein (LDL) Management and Control
Description: Percentage of patients 18 to 75 years of age with diabetes (type 1 or type 2) who had LDL-C <100 mg/dL).
NQF 0061
PQRI 3
Title: Diabetes: Blood Pressure Management
Description: Percentage of patients 18 to 75 years of age with diabetes (type 1 or type 2) who had blood pressure < 140/90 mmHg.
NQF 0081
PQRI 5
Title: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
Description: Percentage of patients aged 18 years and older with a diagnosis of heart failure and LVSD (LVEF lt; 40%) who were prescribed ACE inhibitor or ARB therapy.
NQF 0070
PQRI 7
Title: Coronary Artery Disease (CAD): Beta-Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI)
Description: Percentage of patients aged 18 years and older with a diagnosis of CAD and prior MI who were prescribed beta-blocker therapy.
NQF 0043
PQRI 111
Title: Pneumonia Vaccination Status for Older Adults
Description: Percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine.
NQF 0031
PQRI 112
Title: Breast Cancer Screening
Description: Percentage of women 40 to 69 years of age who had a mammogram to screen for breast cancer.
NQF 0034
PQRI 113
Title: Colorectal Cancer Screening
Description: Percentage of adults 50 to 75 years of age who had appropriate screening for colorectal cancer.
NQF 0067
PQRI 6
Title: Coronary Artery Disease (CAD): Oral Antiplatelet Therapy Prescribed for Patients with CAD
Description: Percentage of patients aged 18 years and older with a diagnosis of CAD who were prescribed oral antiplatelet therapy.
NQF 0083
PQRI 8
Title: Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
Description: Percentage of patients aged 18 years and older with a diagnosis of heart failure who also have LVSD (LVEF lt; 40%) and who were prescribed beta-blocker therapy.
NQF 0105
PQRI 9
Title: Anti-Depressant Medication Management: (a) Effective Acute Phase Treatment,(b)Effective Continuation Phase Treatment
Description: The percentage of patients 18 years of age and older who were diagnosed with a new episode of major depression, treated with antidepressant medication, and who remained on an antidepressant medication treatment.
NQF 0086
PQRI 12
Title: Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation
Description: Percentage of patients aged 18 years and older with a diagnosis of POAG who have been seen for at least two office visits who have an optic nerve head evaluation during one or more office visits within 12 months.
NQF 0088
PQRI 18
Title: Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy
Description: Percentage of patients aged 18 years and older with a diagnosis of diabetic retinopathy who had a dilated macular or fundus exam performed that included documentation of the level of severity of retinopathy and the presence or absence of macular edema during one or more office visits within 12 months.
NQF 0089
PQRI 19
Title: Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
Description: Percentage of patients aged 18 years and older with a diagnosis of diabetic retinopathy who had a dilated macular or fundus exam performed with documented communication to the physician who manages the ongoing care of the patient with diabetes mellitus regarding the findings of the macular or fundus exam at least once within 12 months.
NQF 0047
PQRI 53
Title: Asthma Pharmacologic Therapy
Description: Percentage of patients aged 5 through 40 years with a diagnosis of mild, moderate, or severe persistent asthma who were prescribed either the preferred long-term control medication (inhaled corticosteroid) or an acceptable alternative treatment.
NQF 0001
PQRI 64
Title: Asthma Assessment
Description: Percentage of patients aged 5 through 40 years with a diagnosis of asthma and who have been seen for at least two office visits, who were evaluated during at least one office visit within 12 months for the frequency (numeric) of daytime and nocturnal asthma symptoms.
NQF 0002
PQRI 66
Title: Appropriate Testing for Children with Pharyngitis
Description: Percentage of children 2 to 18 years of age who were diagnosed with pharyngitis, dispensed an antibiotic, and received a group A streptococcus (strep) test for the episode.
NQF 0387
PQRI 71
Title: Oncology Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/Progesterone Receptor (ER/PR) Positive Breast Cancer
Description: Percentage of female patients aged 18 years and older with Stage IC through IIIC, ER or PR positive breast cancer who were prescribed tamoxifen or aromatase inhibitor (AI) during the 12-month reporting period.
NQF 0385
PQRI 72
Title: Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients
Description: Percentage of patients aged 18 years and older with Stage IIIA through IIIC colon cancer who are referred for adjuvant chemotherapy, prescribed adjuvant chemotherapy, or have previously received adjuvant chemotherapy within the 12-month reporting period.
NQF 0389
PQRI 102
Title: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low-Risk Prostate Cancer Patients
Description: Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy, OR cryotherapy who did not have a bone scan performed at any time since diagnosis of prostate cancer.
NQF 0027
PQRI 115
Title: Smoking and Tobacco Use Cessation, Medical Assistance: a. Advising Smokers and Tobacco Users to Quit, b. Discussing Smoking and Tobacco Use Cessation Medications, c. Discussing Smoking and Tobacco Use Cessation Strategies
Description: Percentage of patients 18 years of age and older who were current smokers or tobacco users, who were seen by a practitioner during the measurement year, and who received advice to quit smoking or tobacco use or whose practitioner recommended or discussed smoking or tobacco use cessation medications, methods, or strategies.
NQF 0055
PQRI 117
Title: Diabetes: Eye Exam
Description: Percentage of patients 18 to 75 years of age with diabetes (type 1 or type 2) who had a retinal or dilated eye exam or a negative retinal exam (no evidence of retinopathy) by an eye care professional.
NQF 0062
PQRI 119
Title: Diabetes: Urine Screening
Description: Percentage of patients 18 to 75 years of age with diabetes (type 1 or type 2) who had a nephropathy screening test or evidence of nephropathy.
NQF 0056
PQRI 163
Title: Diabetes: Foot Exam
Description: The percentage of patients aged 18 to 75 years with diabetes (type 1 or type 2) who had a foot exam (visual inspection, sensory exam with monofilament, or pulse exam).
NQF 0074
PQRI 197
Title: Coronary Artery Disease (CAD): Drug Therapy for Lowering LDL Cholesterol
Description: Percentage of patients aged 18 years and older with a diagnosis of CAD who were prescribed a lipid-lowering therapy (based on current ACC/AHA guidelines).
NQF 0084
PQRI 200
Title: Heart Failure (HF): Warfarin Therapy Patients with Atrial Fibrillation
Description: Percentage of all patients aged 18 years and older with a diagnosis of heart failure and paroxysmal or chronic atrial fibrillation who were prescribed warfarin therapy.
NQF 0073
PQRI 201
Title: Ischemic Vascular Disease (IVD): Blood Pressure Management
Description: Percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG), or percutaneous transluminal coronary angioplasty (PTCA) from January 1 through November 1 of the year prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to the measurement year and whose recent blood pressure is in control (< 140/90 mmHg).
NQF 0068
PQRI 204
Title: Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic
Description: Percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG), or percutaneous transluminal coronary angioplasty (PTCA) from January 1 through November 1 of the year prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to the measurement year and who had documentation of use of aspirin or another antithrombotic during the measurement year.
NQF 0004
Title: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment: (a) Initiation, (b) Engagement
Description: The percentage of adolescent and adult patients with a new episode of alcohol and other drug (AOD) dependence who initiate treatment through an inpatient AOD admission, outpatient visit, intensive outpatient encounter, or partial hospitalization within 14 days of the diagnosis and who initiated treatment and who had two or more additional services with an AOD diagnosis within 30 days of the initiation visit.
NQF 0012
Title: Prenatal Care: Screening for Human Immunodeficiency Virus (HIV)
Description: Percentage of patients, regardless of age, who gave birth during a 12-month period who were screened for HIV infection during the first or second prenatal care visit.
NQF 0014
Title: Prenatal Care: Anti-D Immune Globulin
Description: Percentage of D (Rh) negative, unsensitized patients, regardless of age, who gave birth during a 12-month period who received anti-D immune globulin at 26 to 30 weeks gestation.
NQF 0018
Title: Controlling High Blood Pressure
Description: The percentage of patients 18 to 85 years of age who had a diagnosis of hypertension and whose BP was adequately controlled during the measurement year
NQF 0032
Title: Cervical Cancer Screening
Description: Percentage of women 21 to 64 years of age, who received one or more Pap tests to screen for cervical cancer
NQF 0033
Title: Chlamydia Screening for Women
Description: Percentage of women 15 to 24 years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement year.
NQF 0036
Title: Use of Appropriate Medications for Asthma
Description: Percentage of patients 5 to 50 years of age who were identified as having persistent asthma and were appropriately prescribed medication during the measurement year. Report three age stratifications (5-11 years, 12-50 years, and total).
NQF 0052
Title: Low Back Pain: Use of Imaging Studies
Description: Percentage of patients with a primary diagnosis of low back pain who did not have an imaging study (plain X-ray, MRI, CT scan) within 28 days of diagnosis.
NQF 0075
Title: Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control
Description: Percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG), or percutaneous transluminal angioplasty (PTCA) from January 1 through November 1 of the year prior to the measurement year, or who had a diagnosis of ischemic vascular disease (IVD) during the measurement year and the year prior to the measurement year and who had a complete lipid profile performed during the measurement year and whose LDL-C < 100 mg/dL.
NQF 0575
Title: Diabetes: Hemoglobin A1c Control (< 8.0%)
Description: The percentage of patients 18 to 75 years of age with diabetes (type 1 or type 2) who had hemoglobin A1c < 8.0%.
Guideline #12
Patient Electronic Data Portal

Probably more so than any other guideline, this item is a large enhancement or change to existing workflows. This guideline requires that a facility provide patients with an electronic copy of their health information (including diagnostic test results, problem list, medication lists, medication allergies), on request. Ultimately this sets the course for the elimination of traditional paper-based records. Some systems implement this access as a web-based portal that can be used to access the information, others produce PDF files or other exportable documents that can be provided to a patient on a CD-ROM or other electronic sharing medium.

Measure

More than 50% of all patients of the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department) who request an electronic copy of their health information are provided it within three business days.

Guideline #13
Comprehensive Visit Summaries

Provide clinical summaries for patients for each office visit.

Measure

Clinical summaries provided to patients for more than 50% of all office visits within three business days. The clinical summary needs to include a textual summary of the visit, coding and charge information, and as appropriate medications, labs, and other data.

Guideline #14
Clinical Information Exchange

The capability to exchange key clinical information (e.g., problem list, medication list, medication allergies, diagnostic test results) among providers of care and patient-authorized entities electronically. Many people in the healthcare industry, although David is not among them, see electronic clinical information exchange as a panacea of sorts, on one level to resolve problems of duplication in services and data, on another to provide a basis for analysis of data, and finally as a mechanism to improve patient care. Meaningful use strongly sets a foundation for future expansion of clinical information exchange by requiring support of structured data tracking and by requiring support for the CCD exchange format. In the current guidelines this one sets a very low bar for exchange, simply requiring support for the exchange format and that a single test be conducted. At the time of this writing it appears very likely that substantially more in-depth exchange will be necessary to be compliant in the coming years.

Measure

Performed at least one test of information exchange using the CCD (or related) format with another provider organization. For larger facilities this may involve use of a Health Interoperability Exchange (HIE) discussed elsewhere in this text. For most small and medium facilities completing the exchange can be done simply by utilizing some of the support required in other guidelines, specifically file encryption and CCD support. The facility can produce a CCD for a patient, encrypt it, and transfer it to another facility that also has a meaningful use compliant EHR system.

Guideline #15
Protect Health Information

Protect electronic health information created or maintained by the certified EHR technology. This is probably one of the least understood guidelines and in practice is not that large an undertaking for most organizations but on first appearance can seem daunting. The actual heart of this guideline is that as a facility you create a written policy regarding your passwords, access controls, and other electronic and physical measures you take to protect health information and then follow and conduct periodic audits of compliance to the written policy. The specific federal rules that must be reviewed go to pretty long lengths not to codify specific details of the policy that must be in place, only that there be a written policy and it is followed and audited.

Measure

Conduct or review a security risk analysis per 45 CFR 164.308 (a)(1) and implement security updates as necessary and correct identified security deficiencies as part of the risk management process. Implement standardized access, password, and logging policies. Conduct periodic audits against those policies to find noncompliance. The federal regulation is a bit difficult to digest but again the heart of it is just to take steps to create written versions of policies that protect health information and to follow those policies. It prescribes very little by way of what the policies your organization has must contain.

The preceding guidelines are all required. Each guideline and each measure must be compliant for a provider to be eligible to receive incentive dollars. In contrast, the following guidelines present a mix-and-match set that can be selected from. To be compliant, only 5 of the 10 guidelines and measures are required. At a minimum select the five most applicable to your line(s) of care, but there is much to be said for implementing compliance with more if you can. Each successive year will see more thorough and expansive guidelines, so it is better to get ahead of the curve if possible.

Guideline #16
Drug-Formulary Checks

Implement drug-formulary checks for at least one internal and one external formulary. There is often confusion about what exactly a formulary is. It is a preferential list of drugs, doses, and forms that can be put together by a facility to make prescribing more consistent. It is also published by payers to indicate drugs that are covered by their programs.

Measure

The eligible hospital’s or CAH’s inpatient or emergency department has enabled this functionality and has access to at least one internal or external drug formulary for the entire EHR reporting period.

Guideline #17
Lab Results

Incorporate electronic clinical lab test results into certified EHR technology as structured data. All major labs have various kinds of support for electronic importation of results. There can be problems if your facility works primarily with specialty labs or those that are regional or internal. To be compliant the results must be importable into the EHR’s structured electronic data.

Measure

More than 40% of all clinical lab test results ordered by the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department) during the EHR reporting period whose results are either in a positive/negative or numerical format are incorporated in certified EHR technology as structured data. Note that the relatively low threshold of 40% provides ample room for special cases involving regional or onsite labs that are not electronically importable.

Guideline #18
Patient List Reports

Generate lists of patients by specific conditions to use for quality improvement, reduction of disparities, research, or outreach. Of all of the pieces of meaningful use this capability and its potential strike us as the most underrated and most likely to have real-world benefits for patient outcomes. It is shocking just how little data analysis is done by facilities themselves and the capability offers a straightforward and powerful means to get facilities involved in looking at their own patient populations and important statistics about them. That introspection offers what might be the most promising avenue for significant improvements in patient outcomes with a minimum of effort.

Measure

Generate at least one report listing patients of the eligible hospital’s or CAH’s inpatient or emergency department, eligible hospital, or CAH with a specific condition.

Guideline #19
Reminders

Send reminders to patients respecting patient preference for preventive/follow-up care. Many facilities currently employ some process for reminding patients about upcoming interactions. This guideline brings into the electronic age the existing processes and is very synergistic with the patient lists of guideline requirements. This capability has the dramatic potential to improve patient outcomes with minimum effort.

Guideline
Measure

More than 20% of all unique patients 65 years or older or 5 years old or younger were sent an appropriate reminder during the EHR reporting period.

Guideline #20
Patient Access to Health Information

Provide patients with timely electronic access to their health information (including lab results, problem list, medication lists, medication allergies) within four business days of the information being available to the eligible hospital’s or CAH’s inpatient or emergency department. A supplement to the guideline regarding access to electronic visit information, this guideline expands that to the ability to provide a comprehensive record rather than just that of a current visit.

Measure

More than 10% of all unique patients seen by the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department) are provided timely (available to the patient within four business days of being updated in the certified EHR technology) electronic access to their health information subject to the eligible hospital’s or CAH’s inpatient or emergency department’s discretion to withhold certain information. For various reasons providers might choose to exclude certain classes or specific parts of records from this general sharing. Some states do have additional laws regarding access to legally complete records that might apply to this set of capabilities.

Guideline #21
Education

Use certified EHR technology to identify patient-specific education resources and provide those resources to the patient if appropriate. Facilities often have various mediums of patient education resources from videos to handouts and even websites. This guideline builds on the process by requiring documented and structured information about what education has been provided and what level of understanding the patient has regarding the resource.

Measure

More than 10% of all unique patients seen by the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department) are provided patient-specific education resources.

Guideline #22
Medication Reconciliation

The eligible hospital’s or CAH’s inpatient or emergency department that receives a patient from another setting of care or provider of care or believes an encounter is relevant should perform medication reconciliation between the medication details provided by the other facility and any medication records at the currently treating facility. This process in most systems is done by recording the second set of medications as “outside reported” rather than prescribed or ordered and performing duplication, allergy, and contraindication checking among all those entries.

Measure

The eligible hospital’s or CAH’s inpatient or emergency department performs medication reconciliation for more than 50% of transitions of care in which the patient is transitioned into the care of the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department).

Guideline #23
Summary of Care Record

The eligible hospital’s or CAH’s inpatient or emergency department who transitions their patient to another setting of care or provider of care or refers their patient to another provider of care should provide a summary of care record for each transition of care or referral. Similar to the other patient and electronic interchange guidelines, this item just ensures that information sharing is done in a compliant format when transferring patients to other care facilities or settings.

Measure

The eligible hospital’s or CAH’s inpatient or emergency department refers their patient to another setting of care or provider of care or referral care and provides a summary of care record for more than 50% of transitions of care and referrals.

Guideline #24
Immunization Registry Submission

Capability to submit electronic data to immunization registries or immunization information systems and actual submission in accordance with applicable law and practice. This guideline seems to have had the largest amount of errata and additional comment applied by CMS and other authoritative agencies. Although a valiant attempt to improve sharing of data with public health systems, implementation is severely hampered by the limited number and unique requirements of immunization registry systems present at most public health agencies. As a result the guidelines have been watered down to a point of reference only with the submission of very simplistic electronic data by existing means for a single test.

Measure

Perform at least one test of certified EHR technology’s capacity to submit electronic data to immunization registries and follow-up submission if the test is successful (unless none of the immunization registries to which the eligible hospital’s or CAH’s inpatient or emergency department have the capacity to receive the information electronically).

Guideline #25
Syndromic Surveillance Data Submission

Capability to submit electronic syndromic surveillance data to public health agencies and actual submission in accordance with applicable law and practice. This guideline has suffered much the same fate as that regarding immunization registry submission with a number of comments and errata that erodes much of the potential benefit of this. A simple test can be conducted using a variety of formats that might or might not be of practical use. Only a single test must be conducted to comply.

Measure

Perform at least one test of certified EHR technology’s capacity to provide electronic syndromic surveillance data to public health agencies and follow-up submission if the test is successful (unless none of the public health agencies to which an eligible hospital’s or CAH’s inpatient or emergency department submits such information have the capacity to receive the information electronically).

Inpatient Guidelines and Requirements

Although many of these guidelines are similar to those for outpatient facilities, there are enough subtle differences that they are listed here separately.

Because of the fluid nature of the meaningful use requirements and the ongoing rule making it is important to check with the registration website for the latest information.

Guideline #1
Computerized Provider Order Entry (CPOE)

Use of CPOE for medication orders directly entered by any licensed healthcare professional who can enter orders into the medical record per state, local, and professional guidelines. This guideline covers ePrescribing as well as recording of medications that are dispensed and administered within the facility.

Measure

More than 30% of unique patients with at least one medication in their medication list seen by the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department) have at least one medication order entered using CPOE.

Guideline #2
Drug Allergy Checking

Implement drug-drug and drug-allergy interaction checks. Typically this guideline involves both drug to drug allergy and drug to drug contraindications, although there is flexibility in the guidelines text in this regard.

Measure

The eligible hospital’s or CAH’s inpatient or emergency department has enabled this functionality for the entire EHR reporting period.

Guideline #3
Record Demographics

These include preferred language, gender, race, ethnicity, and date of birth. Some of those data points are tracked by most facilities but preferred language, race, and ethnicity are new demographics to many lines of care.

Measure

More than 50% of all unique patients seen by the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department) have demographics recorded as structured data.

Guideline #4
Problem List

Maintain an up-to-date problem list of current and active diagnoses.

Measure

More than 80% of all unique patients seen by the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department) have at least one entry or an indication that no problems are known for the patient recorded as structured data. Structured data here refers to the ability to report distinctly on individual problems by code. Clinical notes that might be recorded during a patient provider interaction are insufficient to comply with this guideline.

Guideline #5
Medication List

Maintain an active medication list detailing medications the patient is actively taking that are prescribed by the provider’s facility or reported by the patient. Again this guideline requires data that can be reported on for each individual medication and cannot be complied with using only text clinical notes.

Measure

More than 80% of all unique patients seen by the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department) have at least one entry (or an indication that the patient is not currently prescribed any medication) recorded as structured data.

Guideline #6
Allergy List

Maintain an active medication allergy list that tracks medication allergies at a minimum. All meaningful use certified systems to date also permit tracking of environmental, food, and other miscellaneous allergies as well as medications.

Measure

More than 80% of all unique patients seen by the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department) have at least one entry (or an indication that the patient has no known medication allergies) recorded as structured data.

Guideline #7
Vital Signs

Record patient vitals as part of typical workflow including height, weight, and blood pressure; and calculate and display BMI and plot and display growth charts for children 2 to 20 years old, including BMI. This measure will be a significant workflow change for many types of facilities not accustomed to tracking vital statistics with this level of detail on each visit. A few select exemptions apply, so please check CMS advisories for more information. The reasoning for this measure even in lines of care where the necessity for vitals might not be immediately apparent is that vital statistics provide a solid evidentiary base for earlier prevention of the most problematic chronic diseases, and each interaction with a provider of any specialty is a good opportunity for this basic prevention step.

Measure

For more than 50% of all unique patients age 2 and over seen by the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department) have height, weight and blood pressure recorded as structured data.

Guideline #8
Smoking Status

Record smoking status for patients 13 years old or older. Again this guideline applies to all specialties even if it has not historically been the case for this information to be tracked and even if it is not immediately obvious how it might be connected. Smoking-related illness remains a significant cause of adverse health and any interaction with a medical provider of any kind is a good opportunity to attempt to stop patients from smoking or to create correlating data about all types of illness and smoking.

Measure

More than 50% of all unique patients 13 years old or older seen by the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department) have smoking status recorded.

Guideline #9
Clinical Decision Support (CDS)

Implement one clinical decision support rule relevant to specialty or high clinical priority along with the ability to track compliance with that rule. Clinical decision support remains the holy grail of EHR in many circles and is an advanced concept where the system can apply logical conditions to known data points and make recommendations or present evidentiary advisements about possible diagnosis, treatment, and outcomes for the patient. It is expected that CDS will play a larger and larger role as guidelines continue to expand in future years. This guideline provides enormous flexibility in how it can be complied with and sets a low bar with only the need to implement a single CDS rule, no matter how simplistic. To a large extent this guidelines is an indicator and placeholder to introduce facilities to the concept. CDS is a radical departure toward consistent and systematized care that is not that common today.

Measure

Implement one clinical decision support rule.

Guideline #10
Report Clinical Quality Measures

Report ambulatory clinical quality measures to CMS or the states. This guideline is the actual step of demonstrating meaningful use compliance by submitting the summarized numbers to provide compliance with each guideline.

Measure

For 2011, provide aggregate numerator, denominator, and exclusions through attestation to the state or federal government through the web-based reporting system. For inpatient facilities the measures are fairly complex and itemized here.

ED–1
NQF 0495
Title: Emergency Department Throughput—Admitted Patients. Median time from ED arrival to ED departure for admitted patients
Description: Median time from emergency department arrival to time of departure from the emergency room for patients admitted to the facility from the emergency department.
ED–2
NQF 0497
Title: Emergency Department Throughput—Admitted Patients. Admission decision time to ED departure time for admitted patients
Description: Median time from admit decision time to time of departure from the emergency department of emergency department patients admitted to inpatient status.
Stroke-2
NQF 0435
Title: Ischemic stroke—Discharge on anti-thrombotics
Description: Ischemic stroke patients prescribed antithrombotic therapy at hospital discharge.
Stroke-3
NQF 0436
Title: Ischemic stroke—Anticoagulation for A-fib/flutter
Description: Ischemic stroke patients with atrial fibrillation/flutter who are prescribed anticoagulation therapy at hospital discharge.
Stroke-4
NQF 0437
Title: Ischemic stroke—Thrombolytic therapy for patients arriving within 2 hours of symptom onset
Description: Acute ischemic stroke patients who arrive at this hospital within 2 hours of time last known well and for whom IV t-PA was initiated at this hospital within 3 hours of time last known well.
Stroke-5
NQF 0438
Title: Ischemic or hemorrhagic stroke—Antithrombotic therapy by day 2
Description: Ischemic stroke patients administered antithrombotic therapy by the end of hospital day 2.
Stroke-6
NQF 0439
Title: Ischemic stroke—Discharge on statins
Description: Ischemic stroke patients with LDL >100 mg/dL, or LDL not measured, or, who were on a lipid-lowering medication prior to hospital arrival are prescribed statin medication at hospital discharge.
Stroke-8
NQF 0440
Title: Ischemic or hemorrhagic stroke—Stroke education
Description: Ischemic or hemorrhagic stroke patients or their caregivers who were given educational materials during the hospital stay addressing all of the following: activation of emergency medical system, need for follow-up after discharge, medications prescribed at discharge, risk factors for stroke, and warning signs and symptoms of stroke.
Stroke-10
NQF 0441
Title: Ischemic or hemorrhagic stroke—Rehabilitation assessment
Description: Ischemic or hemorrhagic stroke patients who were assessed for rehabilitation services.
VTE–1
NQF 0371
Title: VTE prophylaxis within 24 hours of arrival
Description: This measure assesses the number of patients who received VTE prophylaxis or have documentation why no VTE prophylaxis was given the day of or the day after hospital admission or surgery end date for surgeries that start the day of or the day after hospital admission.
VTE–2
NQF 0372
Title: ICU VTE prophylaxis
Description: This measure assesses the number of patients who received VTE prophylaxis or have documentation why no VTE prophylaxis was given the day of or the day after the initial admission (or transfer) to the Intensive Care Unit (ICU) or surgery end date for surgeries that start the day of or the day after ICU admission (or transfer).
VTE–3
NQF 0373
Title: Anticoagulation overlap therapy
Description: This measure assesses the number of patients diagnosed with confirmed VTE who received an overlap of parenteral (intravenous [IV] or subcutaneous [subcu]) anticoagulation and warfarin therapy. For patients who received less than five days of overlap therapy, they must be discharged on both medications. Overlap therapy must be administered for at least five days with an international normalized ratio (INR) ≥ 2 prior to discontinuation of the parenteral anticoagulation therapy or the patient must be discharged on both medications.
VTE–4
NQF 0374
Title: Platelet monitoring on unfractionated heparin
Description: This measure assesses the number of patients diagnosed with confirmed VTE who received IV UFH therapy dosages and had their platelet counts monitored using defined parameters such as a nomogram or protocol.
VTE–5
NQF 0375
Title: VTE discharge instructions
Description: This measure assesses the number of patients diagnosed with confirmed VTE that are discharged to home, to home with home health, home hospice, or discharged/transferred to court/law enforcement on warfarin with written discharge instructions that address all four criteria: compliance issues, dietary advice, follow-up monitoring, and information about the potential for adverse drug reactions or interactions.
VTE–6
NQF 0376
Title: Incidence of potentially preventable VTE
Description: This measure assesses the number of patients diagnosed with confirmed VTE during hospitalization (not present on arrival) who did not receive VTE prophylaxis between hospital admission and the day before the VTE diagnostic testing order date.
Guideline #11
Patient Electronic Data Portal

Probably more so than any other guideline, this item is a large enhancement or change to existing workflows. This guideline requires that a facility provide patients with an electronic copy of their health information (including diagnostic test results, problem list, medication lists, and medication allergies), on request. Ultimately this sets the course for the elimination of traditional paper-based records. Some systems implement this access as a web-based portal that can be used to access the information, and others produce PDF files or other exportable documents that can be provided to a patient on a CD-ROM or other electronic sharing medium.

Measure

More than 50% of all patients of the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department) who request an electronic copy of their health information are provided it within 3 business days.

Guideline #12
Comprehensive Visit Summaries

Provide clinical summaries for patients for each office visit.

Measure

Clinical summaries provided to patients for more than 50% of all office visits within 3 business days. The clinical summary needs to include a textual summary of the visit, coding and charge information, and, as appropriate, medications, labs, and other data.

Guideline #13
Clinical Information Exchange

The capability to exchange key clinical information (e.g., problem list, medication list, medication allergies, diagnostic test results) among providers of care and patient-authorized entities electronically. Many people in the healthcare industry, although David is not among them, see electronic clinical information exchange as a panacea of sorts, on one level to resolve problems of duplication in services and data, and on another to provide a basis for analysis of data and finally as a mechanism to improve patient care. Meaningful use sets a strong foundation for future expansion of clinical information exchange by requiring support of structured data tracking and by requiring support for the CCD exchange format. In the current guidelines this one sets a very low bar for exchange, simply requiring support for the exchange format and that a single test be conducted. At the time of this writing it appears very likely that substantially more in-depth exchange will be necessary to be compliant in the coming years.

Measure

Perform at least one test of information exchange using the CCD (or related) format with another provider organization. For larger facilities this may involve use of an HIE, discussed elsewhere in this text. For most small and medium facilities completing the exchange can be done simply by utilizing some of the support required in other guidelines, specifically file encryption and CCD support. The facility can produce a CCD for a patient, encrypt it, and transfer it to another facility that also has a meaningful use compliant EHR system.

Guideline #14
Protect Health Information

Protect electronic health information created or maintained by the certified EHR technology. This is probably one of the least understood guidelines and in practice is not that large an undertaking for most organizations, but on first appearance it can seem daunting. The actual heart of this guideline is that as a facility you create a written policy regarding your passwords, access controls, and other electronic and physical measures you take to protect health information and then follow and conduct periodic audits of compliance with the written policy. The specific federal rules that must be reviewed go to pretty long lengths not to codify specific details of the policy that must be in place, only that there be a written policy and it is followed and audited.

Measure

Conduct or review a security risk analysis per 45 CFR 164.308 (a)(1) and implement security updates as necessary and correct identified security deficiencies as part of its risk management process. Implement standardized access, password, and logging policies. Conduct periodic audits against those policies to find noncompliance. The federal regulation is a bit difficult to digest but again the heart of it is just to take steps to create written versions of policies that protect health information and to follow those policies. It prescribes very little by way of what the policies your organization has must contain.

The preceding guidelines are all required. Each guideline and each measure must be compliant for a provider to be eligible to receive incentive dollars. In contrast, the following guidelines present a mix-and-match set that can be selected from. To be compliant, only 5 of the 10 guidelines and measures are required. At a minimum select the five most applicable to your line(s) of care, but there is much to be said for implementing compliance with more if you can. Each successive year will see more thorough and expansive guidelines, so it is better to get ahead of the curve if possible.

Guideline #15
Drug-Formulary Checks

Implement drug-formulary checks for at least one internal and one external formulary. There is often confusion about what exactly a formulary is. It is a preferential list of drugs, doses, and forms that can be put together by a facility to make prescribing more consistent. It is also published by payers to indicate drug costs covered by their programs.

Measure

The eligible hospital’s or CAH’s inpatient or emergency department has enabled this functionality and has access to at least one internal or external drug formulary for the entire EHR reporting period.

Guideline #16
Lab Results

Incorporate electronic clinical lab test results into certified EHR technology as structured data. All major labs have various kinds of support for electronic importation of results. There can be problems if your facility works primarily with specialty labs or those that are regional or internal. To be compliant the results must be importable into the EHR’s structured electronic data.

Measure

More than 40% of all clinical lab tests results ordered by the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department) during the EHR reporting period whose results are either in a positive/negative or numerical format are incorporated in certified EHR technology as structured data. Note that the relatively low threshold of 40% provides ample room for special cases involving regional or onsite labs that are not electronically importable.

Guideline #17
Patient List Reports

Generate lists of patients by specific conditions to use for quality improvement, reduction of disparities, research, or outreach. Of all of the pieces of meaningful use this capability and its potential strike us as the most underrated and most likely to have real-world benefits for patient outcomes. It is shocking just how little data analysis is done by facilities themselves and the capability offers a straightforward and powerful means to get facilities involved in looking at their own patient populations and important statistics about them. That introspection offers what might be the most promising avenue for significant improvements in patient outcomes with a minimum of effort.

Measure

Generate at least one report listing patients of the eligible hospital’s or CAH’s inpatient or emergency department, eligible hospital or CAH with a specific condition

Guideline #18
Reminders

Send reminders to patients respecting patient preference for preventive/follow-up care. Many facilities currently employ some process for reminding patients about upcoming interactions. This guideline brings into the electronic age the existing processes and when combined with the patient lists guideline requirements is very synergistic. This capability has the dramatic potential to improve patient outcomes with minimum effort.

Measure

More than 20% of all unique patients 65 years or older or 5 years old or younger were sent an appropriate reminder during the EHR reporting period.

Guideline #19
Patient Access to Health Information

Provide patients with timely electronic access to their health information (including lab results, problem list, medication lists, and medication allergies) within four business days of the information being available to the eligible hospital’s or CAH’s inpatient or emergency department. A supplement to the guideline regarding access to electronic visit information, this guideline expands that to the ability to provide a comprehensive record rather than just that of a current visit.

Measure

More than 10% of all unique patients seen by the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department) are provided timely (available to the patient within four business days of being updated in the certified EHR technology) electronic access to their health information subject to the eligible hospital’s or CAH’s inpatient or emergency department’s discretion to withhold certain information. For various reasons providers might choose to exclude certain classes or specific parts of records from this general sharing. Some states do have additional laws regarding access to legally complete records that might apply to this set of capabilities.

Guideline #20
Education

Use certified EHR technology to identify patient-specific education resources and provide those resources to the patient if appropriate. Facilities often have various mediums of patient education resources from videos to handouts and even websites. This guideline builds on the process by requiring documented and structured information about what education has been provided and what level of understanding the patient has regarding the resource.

Measure

More than 10% of all unique patients seen by the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department) are provided patient-specific education resources.

Guideline #21
Medication Reconciliation

The eligible hospital’s or CAH’s inpatient or emergency department who receives a patient from another setting of care or provider of care or believes an encounter is relevant should perform medication reconciliation between the medication details provided by the other facility and any medication records at the currently treating facility. This process in most systems is done by recording the second set of medications as “outside reported” rather than prescribed or ordered and performing duplication, allergy, and contraindication checking among all those entries.

Measure

The eligible hospital’s or CAH’s inpatient or emergency department performs medication reconciliation for more than 50% of transitions of care in which the patient is transitioned into the care of the eligible provider (eligible hospital’s or CAH’s inpatient or emergency department).

Guideline #22
Summary of Care Record

The eligible hospital’s or CAH’s inpatient or emergency department that transitions their patient to another setting of care or provider of care or refers their patient to another provider of care should provide a summary of care record for each transition of care or referral. Similar to the other patient and electronic interchange guidelines, this item just ensures that information sharing is done in a compliant format when transferring patients to other care facilities or settings.

Measure

The eligible hospital’s or CAH’s inpatient or emergency department refers their patient to another setting of care or provider of care or referral provides a summary of care record for more than 50% of transitions of care and referrals.

Guideline #23
Immunization Registry Submission

Capability to submit electronic data to immunization registries or immunization information systems and actual submission in accordance with applicable law and practice. This guideline seems to have had the largest amount of errata and additional comment applied by CMS and other authoritative agencies. Although a valiant attempt to improve sharing of data with public health systems, implementation is severely hampered by the limited number and unique requirements of immunization registry systems present at most public health agencies. As a result the guidelines have been watered down to a point of reference only with the submission of very simplistic electronic data by existing means for a single test.

Measure

Perform at least one test of certified EHR technology’s capacity to submit electronic data to immunization registries and follow-up submission if the test is successful (unless none of the immunization registries to which the eligible hospital’s or CAH’s inpatient or emergency department have the capacity to receive the information electronically).

Guideline #24
Syndromic Surveillance Data Submission

Capability to submit electronic syndromic surveillance data to public health agencies and actual submission in accordance with applicable law and practice. This guideline has suffered much the same fate as that regarding immunization registry submission, with a number of comments and errata that erode much of the potential benefit of this. A simple test can be conducted using a variety of formats that might or might not be of practical use. Only a single test must be conducted to comply.

Measure

Perform at least one test of certified EHR technology’s capacity to provide electronic syndromic surveillance data to public health agencies and follow-up submission if the test is successful (unless none of the public health agencies to which an eligible hospital’s or CAH’s inpatient or emergency department submits such information have the capacity to receive the information electronically).

Guideline #25
Advance Directive

Enable a user to electronically record whether a patient has an advance directive. An advance directive is a legal document often called an advance healthcare directive that is created by a patient or his or her legal guardian and instructs providers what actions they can and cannot take in the event the patient is no longer able to make decisions due to illness or incapacity, and appoints a person to make such decisions on his or her behalf.

Measure

Implement the capability to record whether a patient has an advance directive.

..................Content has been hidden....................

You can't read the all page of ebook, please click here login for view all page.
Reset